• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝状噬菌体病毒粒子在抗原呈递细胞中的加工靶向HLA I类和II类肽装载区室。

Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments.

作者信息

Gaubin Muriel, Fanutti Cristina, Mishal Zohar, Durrbach Antoine, De Berardinis Piergiuseppe, Sartorius Rossella, Del Pozzo Giovanna, Guardiola John, Perham Richard N, Piatier-Tonneau Dominique

机构信息

Génomique Fonctionnelle et Biologie Systémique en Santé, Centre National de la Recherche Scientifique, Villejuif, France.

出版信息

DNA Cell Biol. 2003 Jan;22(1):11-8. doi: 10.1089/104454903321112451.

DOI:10.1089/104454903321112451
PMID:12590733
Abstract

Virions of filamentous bacteriophage fd are capable of displaying multiple copies of peptide epitopes and generating powerful immune responses to them. To investigate the antigen processing mechanisms in human B cell lines used as antigen presenting cells, the major coat protein (pVIII) in intact virions was fluorescently labeled, and its localization in various intracellular compartments was followed using confocal microscopy. We show that the virions were taken up and processed to yield peptides that reach both the major histocompatibility complex (MHC) class II compartment and the endoplasmic reticulum. Moreover, when exposed to bacteriophages displaying a cytotoxic T lymphocyte (CTL) epitope from the reverse transcriptase of human immunodeficiency virus type-1 (HIV-1), B cells were lysed by specific cytotoxic lymphocytes. This confirms that filamentous bacteriophage virions are capable of being taken up and processed efficiently by MHC class I and class II pathways, even in nonprofessional antigen presenting cells. These remarkable features explain, at least in part, the unexpected ability of virions displaying foreign T-cell epitopes to prime strong T-helper-dependent CTL responses. These findings have important implications for the development of peptide-based vaccines, using filamentous bacteriophage virions as scaffolds.

摘要

丝状噬菌体fd的病毒粒子能够展示多个拷贝的肽表位,并对其产生强大的免疫反应。为了研究用作抗原呈递细胞的人B细胞系中的抗原加工机制,对完整病毒粒子中的主要衣壳蛋白(pVIII)进行荧光标记,并使用共聚焦显微镜追踪其在各种细胞内区室中的定位。我们发现,病毒粒子被摄取并加工,产生的肽可到达主要组织相容性复合体(MHC)II类区室和内质网。此外,当暴露于展示来自人类免疫缺陷病毒1型(HIV-1)逆转录酶的细胞毒性T淋巴细胞(CTL)表位的噬菌体时,B细胞会被特异性细胞毒性淋巴细胞裂解。这证实了丝状噬菌体病毒粒子即使在非专职抗原呈递细胞中也能够通过MHC I类和II类途径被有效摄取和加工。这些显著特征至少部分解释了展示外源T细胞表位的病毒粒子引发强烈的T辅助细胞依赖性CTL反应的意外能力。这些发现对于以丝状噬菌体病毒粒子为支架开发基于肽的疫苗具有重要意义。

相似文献

1
Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments.丝状噬菌体病毒粒子在抗原呈递细胞中的加工靶向HLA I类和II类肽装载区室。
DNA Cell Biol. 2003 Jan;22(1):11-8. doi: 10.1089/104454903321112451.
2
Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses.来自HIV-1的肽表位的噬菌体展示引发强烈的细胞溶解反应。
Nat Biotechnol. 2000 Aug;18(8):873-6. doi: 10.1038/78490.
3
Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.不变链作为一种载体,将抗原肽加载到人 MHC Ⅰ类分子上,用于细胞毒性 T 细胞的激活。
Eur J Immunol. 2014 Mar;44(3):774-84. doi: 10.1002/eji.201343671. Epub 2013 Dec 27.
4
Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.I类限制性同种异体反应性细胞毒性T淋巴细胞识别一系列复杂的特定MHC相关肽。
J Immunol. 1998 Feb 1;160(3):1091-7.
5
Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.诱导针对HIV-1逆转录酶功能序列中一个新型保守表位的原发性人细胞毒性T淋巴细胞应答。
AIDS. 1995 Feb;9(2):121-7.
6
Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.当肽在共同的蛋白质载体自身免疫球蛋白内给药时,主要组织相容性复合体I类和II类产物递呈的对比功效。
Eur J Immunol. 1993 Nov;23(11):2746-50. doi: 10.1002/eji.1830231104.
7
Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.克氏锥虫感染不会损害主要组织相容性复合体I类分子向细胞毒性T淋巴细胞呈递抗原的功能。
Eur J Immunol. 1997 Oct;27(10):2541-8. doi: 10.1002/eji.1830271012.
8
Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.I类主要组织相容性复合体(MHC)对MUC1肿瘤抗原的呈递以及细胞毒性T淋巴细胞(CTL)功能与树突状细胞摄取的该蛋白的糖基化状态相关。
Cell Immunol. 1999 Jun 15;194(2):143-9. doi: 10.1006/cimm.1999.1512.
9
MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.B细胞中MHC II类抗原加工:抗原在细胞内的靶向加速
J Immunol. 1999 Jun 15;162(12):7171-80.
10
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.细菌抗原递呈系统:细菌抗原的吞噬加工,用于MHC-I和MHC-II呈递给T细胞。
Behring Inst Mitt. 1997 Feb(98):197-211.

引用本文的文献

1
Bacteriophages as Targeted Therapeutic Vehicles: Challenges and Opportunities.作为靶向治疗载体的噬菌体:挑战与机遇
Bioengineering (Basel). 2025 Apr 29;12(5):469. doi: 10.3390/bioengineering12050469.
2
Evaluation of immunogenicity and protective efficacy of bacteriophage conjugated haemagglutinin based subunit vaccine against equine influenza virus in a murine model.评估噬菌体缀合血凝素亚单位疫苗对马流感病毒在小鼠模型中的免疫原性和保护效力。
Vet Res Commun. 2024 Jun;48(3):1707-1726. doi: 10.1007/s11259-024-10356-6. Epub 2024 Mar 26.
3
Aspects of Phage-Based Vaccines for Protein and Epitope Immunization.
基于噬菌体的蛋白质和表位免疫疫苗的相关方面。
Vaccines (Basel). 2023 Feb 14;11(2):436. doi: 10.3390/vaccines11020436.
4
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer.展示HER2的M13噬菌体诱导针对乳腺癌的治疗性免疫。
Cancers (Basel). 2022 Aug 22;14(16):4054. doi: 10.3390/cancers14164054.
5
Systemically targeted cancer immunotherapy and gene delivery using transmorphic particles.使用变形颗粒进行系统性靶向癌症免疫疗法和基因传递。
EMBO Mol Med. 2022 Aug 8;14(8):e15418. doi: 10.15252/emmm.202115418. Epub 2022 Jun 27.
6
Bacteriophages as Therapeutic and Diagnostic Vehicles in Cancer.噬菌体作为癌症治疗和诊断的载体
Pharmaceuticals (Basel). 2021 Feb 17;14(2):161. doi: 10.3390/ph14020161.
7
Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy.基于噬菌体展示的纳米技术在癌症免疫治疗中的应用。
Molecules. 2020 Feb 14;25(4):843. doi: 10.3390/molecules25040843.
8
Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies.武装丝状噬菌体——一种天然纳米颗粒,用于新型疫苗和免疫治疗策略。
Pharmaceutics. 2019 Sep 1;11(9):437. doi: 10.3390/pharmaceutics11090437.
9
Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection.噬菌体触发抗病毒免疫,防止细菌感染清除。
Science. 2019 Mar 29;363(6434). doi: 10.1126/science.aat9691.
10
Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract.热响应性噬菌体纳米载体作为靶向胃肠道的基因传递载体
Mol Ther Nucleic Acids. 2018 Sep 7;12:33-44. doi: 10.1016/j.omtn.2018.04.012. Epub 2018 May 1.